Renaptys Vaccines
Chemicals & Related Products · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.renaptys.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Renaptys Vaccines
Renaptys Vaccines, LLC is focused on developing a proprietary Stable Peptide Immunogen (SPI) platform, which represents a new class of synthetic vaccines that are more effective and cost-efficient to manufacture, store, and ship. Their lead candidate, REN-1005P, is a computationally designed synthetic universal vaccine targeting the influenza virus, including various strains. The company aims to stimulate a meaningful humoral response against the HA stalk of the influenza virus. Renaptys Vaccines, LLC is positioned to serve clients in the pharmaceutical and healthcare sectors seeking innovative vaccine solutions.Explore more
Popular SearchesRenaptys Vaccines LLCSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Renaptys Vaccines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Renaptys Vaccines
Funding: Get notified immidiatlly once Renaptys Vaccines has new funding data
Check if Renaptys Vaccines has recently received funding, and reach out quickly before it becomes old news!
Check out if Renaptys Vaccines is spiking on competitors!
Product Launch: Get notified when Renaptys Vaccines launches new products
Earning: See what the market has to say on Renaptys Vaccines recently announced quarterly report
Website visits: Recent activity has been detected on your website
Renaptys Vaccines, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Renaptys Vaccines had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Renaptys Vaccines
Compare insights from companies similar to Renaptys Vaccines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Renaptys Vaccines
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Renaptys Vaccines is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Renaptys Vaccines is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Renaptys Vaccines.
Renaptys Vaccines Tech Stack
A closer look at the technologies used by Renaptys Vaccines
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Renaptys Vaccines
Sign Up For FreeTo access detailed company insights
Renaptys Vaccines, LLC is focused on developing a proprietary Stable Peptide Immunogen (SPI) platform, which represents a new class of synthetic vaccines that are more effective and cost-efficient to manufacture, store, and ship. Their lead candidate, REN-1005P, is a computationally designed synthetic universal vaccine targeting the influenza virus... Read More
